Auro Laboratories informs about quarterly statement on investor complaints

11 Jan 2017 Evaluate

Auro Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Auro Laboratories Share Price

259.95 -1.55 (-0.59%)
29-Dec-2025 12:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1727.80
Dr. Reddys Lab 1262.90
Cipla 1500.50
Zydus Lifesciences 904.60
Lupin 2096.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×